Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IMUGENE LIMITED Major Shareholding Notification 2015

Oct 27, 2015

65124_rns_2015-10-27_f658af4c-13b0-4aa6-8f1d-30555245983b.pdf

Major Shareholding Notification

Open in viewer

Opens in your device viewer

DocuSign Envelope ID: E4135827-D022-4314-B32E-C31B1635BEC2

605 Page 1 of 2 15 July 2001

Form 605

Corporations Act 2001

Section 671B

Notice of ceasing to be a substantial holder

To Company Name/Scheme Imugene Limited

ACN/ARSN 009 179 551

1. Details of substantial holder (1)

Name Paul Hopper

ACN/ARSN (if applicable)

The holder ceased to be a substantial holder on 26 / 10 / 2015

The previous notice was given to the company on 16 / 12 / 2014 The previous notice was dated 16 / 12 / 2014

2. Changes in relevant interests

Particulars of each change in, or change in the nature of, a relevant interest (2) of the substantial holder or an associate (3) in voting securities of the company or scheme, since the substantial holder was last required to give a substantial holding notice to the company or scheme are as follows:

Date of
change
Person whose
relevant interest
changed
Nature of change (4) Consideration given
in relation to change
(5)
Class (6) and
number of
securities affected
Person's votes
affected
26/10/2015 Paul Hopper Decrease in
percentage
holding to
under 5% due
to Imugene
Share Issue
(No sale of
shares)
N/A N/A Kilinwata
Investments
Pty Ltd, Ms
Deborah Anne
Coleman &
Moreglade Pty
Ltd (all
associated
entities of
Paul Hopper)

3. Changes in association

The persons who have become associates (3) of, ceased to be associates of, or have changed the nature of their association (7) with, the substantial holder in relation to voting interests in the company or scheme are as follows:

Name and ACN/ARSN (if applicable) Nature of association
- -
- -

4. Addresses

The addresses of persons named in this form are as follows:

Name Address
Paul Hopper Suite 1, 1233 High Street
Armadale VIC 3142

DocuSign Envelope ID: E4135827-D022-4314-B32E-C31B1635BEC2

605 Page 2 of 2 15 July 2001

Signature

re
print name
sign here
Paul Hopper
capacity
date
28/10/2015

DIRECTIONS

  • (1) If there are a number of substantial holders with similar or related relevant interests (eg. a corporation and its related corporations, or the manager and trustee of an equity trust), the names could be included in an annexure to the form. If the relevant interests of a group of persons are essentially similar, they may be referred to throughout the form as a specifically named group if the membership of each group, with the names and addresses of members is clearly set out in paragraph 4 of the form.

  • (2) See the definition of "relevant interest" in sections 608 and 671B(7) of the Corporations Act 2001.

  • (3) See the definition of "associate" in section 9 of the Corporations Act 2001.

  • (4) Include details of:

  • (a) any relevant agreement or other circumstances because of which the change in relevant interest occurred. If subsection 671B(4) applies, a copy of any document setting out the terms of any relevant agreement, and a statement by the person giving full and accurate details of any contract, scheme or arrangement, must accompany this form, together with a written statement certifying this contract, scheme or arrangement; and

  • (b) any qualification of the power of a person to exercise, control the exercise of, or influence the exercise of, the voting powers or disposal of the securities to which the relevant interest relates (indicating clearly the particular securities to which the qualification applies).

  • See the definition of "relevant agreement" in section 9 of the Corporations Act 2001.

  • (5) Details of the consideration must include any and all benefits, money and other, that any person from whom a relevant interest was acquired has, or may, become entitled to receive in relation to that acquisition. Details must be included even if the benefit is conditional on the happening or not of a contingency. Details must be included of any benefit paid on behalf of the substantial holder or its associate in relation to the acquisitions, even if they are not paid directly to the person from whom the relevant interest was acquired.

  • (6) The voting shares of a company constitute one class unless divided into separate classes.

  • (7) Give details, if appropriate, of the present association and any change in that association since the last substantial holding notice.